BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 41 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $146,000 | -90.5% | 138,000 | -89.4% | 0.00% | -100.0% |
| Q1 2016 | $1,537,000 | +219.5% | 1,296,000 | +262.0% | 0.00% | – |
| Q3 2015 | $481,000 | +37.4% | 358,000 | +62.7% | 0.00% | – |
| Q2 2015 | $350,000 | -45.5% | 220,000 | -58.0% | 0.00% | – |
| Q4 2014 | $642,000 | +155.8% | 524,000 | +128.8% | 0.00% | – |
| Q3 2014 | $251,000 | -87.5% | 229,000 | -87.8% | 0.00% | -100.0% |
| Q4 2013 | $2,012,000 | – | 1,881,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,340,750,000,000 | 1.66% |
| OAKTREE CAPITAL MANAGEMENT LP | 66,800,000 | $70,446,000 | 1.23% |
| Man Investments (CH) AG | 2,600,000 | $2,743,000 | 1.11% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,425,000 | 0.81% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,763,000 | $38,870,000 | 0.58% |
| Jabre Capital Partners S.A. | 5,900,000 | $6,240,000 | 0.44% |
| SSI INVESTMENT MANAGEMENT LLC | 3,039,000 | $3,198,000 | 0.31% |
| AVIVA PLC | 37,700,000 | $39,724,000 | 0.30% |
| BNP PARIBAS FINANCIAL MARKETS | 3,000,000 | $315,929,984,000 | 0.30% |
| Calamos Advisors LLC | 44,222,000 | $46,596,000 | 0.30% |